Therapyraftsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-09-07
Share capital
5,000.00 PLN
Registered address
ul. Zygmunta Sierakowskiego 50/2, 51-678 Wrocław, Poland
Electronic delivery address
AE:PL-58497-16850-AFUFT-30

Financials

Revenue history

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 124 days for 2022).

  • 202530/03/2026
  • 202406/11/2025
  • 202308/07/2024
  • 202216/11/2023
  • 202111/10/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Authorized Representatives

Jacek Andrzej Raźniewski – Attorney-in-fact (sole)
Łukasz Paweł Nieradko – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented by the President of the Management Board independently. In the case of a multi-member management board, the company is represented by the President of the Management Board independently, or by the Vice-President independently, or by two members of the management board acting jointly. If an independent commercial proxy is appointed, the commercial proxy is authorised to submit declarations of will and sign on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Łukasz Paweł Nieradkoage 54
25$337.6625%
Andrzej Marek Rapakage 67
25$337.6625%
Jacek Andrzej Raźniewskiage 69
25$337.6625%
Maciej Zygmunt Siewińskiage 75
25$337.6625%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
CryptomageS.A.
MedisensonicS.A.
123labs.Eusp. z o.o.
Aliatechnicssp. z o.o.
Deepstributedsp. z o.o.
Bekarsp. z o.o.
Quetzsp. z o.o.
Medi Magentasp. z o.o.
Advanced Technologysp. z o.o.
Exomovessp. z o.o.

FAQ

Last updated: 2026-03-31